Zika virus
The Massachusetts-based startup aims to advance testing for parasitic and viral diseases including Chagas, Zika, Lyme, and tapeworm and liver fluke infections.
The method uses standard lab equipment and the nanoswitches can be easily reconfigured and made in large batches at a cost of about $0.01 per reaction.
Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Premium
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
Grifols ART System Nabs FDA Approval
The system is approved for use with the Procleix Ultrio Elite Assay, the Procleix WNV Assay, Procleix Zika Virus Assay, and the Procelix Babesia Assay.
Broad Institute Researchers Develop Viral Detection Platform Based on Microfluidics, CRISPR Tech
The platform can detect a single virus in more than 1,000 samples at a time or more than 160 viruses, including SARS-CoV-2, in a small number of samples.